Oscar Health (NYSE:OSCR) CFO Richard Scott Blackley Sells 18,750 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 18,750 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $31.74, for a total transaction of $595,125.00. Following the completion of the sale, the chief financial officer directly owned 56,250 shares of the company’s stock, valued at $1,785,375. This trade represents a 25.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Richard Scott Blackley also recently made the following trade(s):

• On Tuesday, June 2nd, Richard Scott Blackley sold 31,683 shares of Oscar Health stock. The stock was sold at an average price of $21.94, for a total value of $695,125.02.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $31.31 on Friday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $9.66 billion, a price-to-earnings ratio of 22.36, a price-to-earnings-growth ratio of 0.67 and a beta of 2.36. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $33.48. The business has a 50 day simple moving average of $29.95 and a 200-day simple moving average of $21.37.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $0.40 by $0.70. The company had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. Oscar Health’s revenue was up 70.4% compared to the same quarter last year. During the same quarter last year, the business earned ($0.89) earnings per share. As a group, equities research analysts expect that Oscar Health, Inc. will post 1.54 earnings per share for the current year.

Institutional Trading of Oscar Health

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Oscar Health by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after acquiring an additional 540,851 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Oscar Health by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock valued at $68,964,000 after buying an additional 116,430 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH raised its position in shares of Oscar Health by 1,097.8% during the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock valued at $3,418,000 after buying an additional 218,022 shares in the last quarter. BIT Capital GmbH lifted its position in shares of Oscar Health by 545.0% during the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after purchasing an additional 5,227,152 shares during the last quarter. Finally, Simplify Asset Management Inc. bought a new position in shares of Oscar Health during the 4th quarter worth approximately $2,948,000. 75.70% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently weighed in on OSCR. Robert W. Baird set a $27.00 target price on shares of Oscar Health in a research note on Friday, August 7th. Piper Sandler reissued an “overweight” rating and issued a $36.00 target price on shares of Oscar Health in a research note on Tuesday, July 28th. Wells Fargo & Company increased their price target on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research report on Thursday, August 13th. Weiss Ratings raised Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Finally, Wolfe Research started coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They set a “peer perform” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, Oscar Health presently has a consensus rating of “Hold” and an average price target of $26.22.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.